Literature DB >> 28862226

Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.

Gokul Sridharan1, Pratibha Ramani2, Sangeeta Patankar1.   

Abstract

CONTEXT: Metabolomics is a core discipline of system biology focusing on the study of low molecular weight compounds in biological system. Analysis of human metabolome, which is composed of diverse group of metabolites, can aid in diagnosis and prognosis of oral squamous cell carcinoma (OSCC). AIM: The aim of the present study is to analyze and identify serum metabolites in oral leukoplakia and OSCC as a potential diagnostic biomarker and a predictor for malignant transformation of oral leukoplakia. SUBJECTS AND METHODS: Serum metabolomic profile of patients diagnosed with oral leukoplakia (n = 21) and OSCC (n = 22) was compared with normal controls (n = 18) using quadrupole time of flight-liquid chromatography-mass spectrometry. MassHunter profile software was used for metabolite identification, and statistical analysis to assess the variation of the metabolites was performed using Mass Profiler Professional software. Statistical significance between the three groups was expressed using ANOVA (P < 0.05), and intergroup comparison was done using Student's t-test (P < 0.05).
RESULTS: Significant upregulation of estradiol-17-beta-3-sulfate, L-carnitine, 5-methylthioadenosine (MTA), 8-hydroxyadenine, 2-methylcitric acid, putrescine, and estrone-3-sulfate was seen in oral leukoplakia and OSCC than in normal controls. Furthermore, significant upregulation of 5,6-dihydrouridine, 4-hydroxypenbutolol glucuronide, 8-hydroxyadenine, and putrescine was evident in OSCC group than in oral leukoplakia.
CONCLUSION: Upregulation of L-carnitine, lysine, 2-methylcitric acid, putrescine; 8-hydroxyadenine; 17-estradiol; 5,6-dihydrouridine; and MTA suggests their diagnostic potential in oral leukoplakia and OSCC. Further, a significant upregulation of putrescine, 8-hydroxyadenine, and 5,6-dihydrouridine in OSCC than in oral leukoplakia indicates their potential role in predicting the malignant transformation of oral leukoplakia.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28862226     DOI: 10.4103/jcrt.JCRT_1233_16

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  12 in total

1.  Metabolomics of Oral/Head and Neck Cancer.

Authors:  Gaofei Yin; Junwei Huang; Wei Guo; Zhigang Huang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Prevalence of oral mucocele among outpatients at saveetha dental hospital, india.

Authors:  Shalini Sathiyamoorthy; S Gheena; Ravindra Kumar Jain
Journal:  Bioinformation       Date:  2020-12-31

3.  Insights from an awareness survey on Oral Submucous Fibrosis (OSMF).

Authors:  Harippriya Karthikeyan; Abilasha Ramasubramanian; Visalakshi Ramanathan
Journal:  Bioinformation       Date:  2020-12-31

4.  Dynamic changes of serum cytokines in acute paraquat poisoning and changes in patients' immune function.

Authors:  Huimin Yuan; Qian Liu; Yulan Yu
Journal:  IET Syst Biol       Date:  2022-06-27       Impact factor: 1.468

5.  Untargeted Metabolomics Reveals Molecular Effects of Ketogenic Diet on Healthy and Tumor Xenograft Mouse Models.

Authors:  David Licha; Silvia Vidali; Sepideh Aminzadeh-Gohari; Oliver Alka; Leander Breitkreuz; Oliver Kohlbacher; Roland J Reischl; René G Feichtinger; Barbara Kofler; Christian G Huber
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 6.  Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function.

Authors:  Alexander Gardner; Guy Carpenter; Po-Wah So
Journal:  Metabolites       Date:  2020-01-26

7.  Metabolome and microbiome of chronic periapical periodontitis in permanent anterior teeth: a pilot study.

Authors:  Yun Huang; Peng Zhou; Siqi Liu; Wei Duan; Qinqin Zhang; Ying Lu; Xin Wei
Journal:  BMC Oral Health       Date:  2021-11-23       Impact factor: 2.757

Review 8.  Panomics for Precision Medicine.

Authors:  Charanjit Sandhu; Alia Qureshi; Andrew Emili
Journal:  Trends Mol Med       Date:  2017-12-05       Impact factor: 15.272

9.  The Oral Mouse Microbiome Promotes Tumorigenesis in Oral Squamous Cell Carcinoma.

Authors:  Philip Stashenko; Susan Yost; Yoonhee Choi; Theodora Danciu; Tsute Chen; Subbiah Yoganathan; Christine Kressirer; Montserrat Ruiz-Tourrella; Bikul Das; Alexis Kokaras; Jorge Frias-Lopez
Journal:  mSystems       Date:  2019-08-06       Impact factor: 6.496

10.  Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.

Authors:  Mengxue Zhang; Xiao Chen; He Chen; Minyue Zhou; Yaoqiang Liu; Yali Hou; Minhai Nie; Xuqian Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.